Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.

Shares in Sarepta Therapeutics have slumped by more than a third since late last week amid new updates on its gene therapy ...

Asian markets are mixed after U.S. stock indexes hit new records on Monday. Oil prices fell and U.S. futures were little ...

World shares were mixed on Tuesday after US stock indexes inched to more records at the start of a week of profit updates ...